Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Reid

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Seminars in Oncology|March 10, 2020
Locally advanced rectal cancer: The past, present, and futureBryan Oronsky, Tony Reid, Chris Larson, et al.
American Journal of Cancer Research|May 9, 2022
The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenograftsTony Reid, Bryan Oronsky, Nacer Abrouk, et al.
International Journal of Medical Sciences|October 14, 2022
Superficial Venous-Associated Inflammation from Direct IV Administration of RRx-001 in RatsScott Caroen, Bryan Oronsky, Tony Reid, et al.
Lancet (London, England)|September 23, 2014
Calling tuberculosis a social disease--an excuse for complacency?Petros Isaakidis, Stella Smith, Suman Majumdar, et al.
Translational Oncology|June 29, 2012
Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a reviewBryan T Oronsky, Jan J Scicinski, Tony Reid, et al.
Seminars in Oncology|June 11, 2020
Just eat it: A review of CD47 and SIRP-α antagonismBryan Oronsky, Corey Carter, Tony Reid, et al.
Molecular Cancer Therapeutics|February 1, 2024
Predicting the Abscopal Phenomenon-Letter to the EditorAnthony P Conley, Bryan Oronsky, Scott Caroen, et al.
Einstein (Sao Paulo, Brazil)|February 4, 2014
Mortality in a pediatric secondary-care hospital in post-conflict Liberia in 2009Thomaz Bittencourt Couto, Sylvia Costa Lima Farhat, Tony Reid, et al.
Translational Oncology|September 1, 2012
The scarlet letter of alkylation: a mini review of selective alkylating agentsBryan T Oronsky, Tony Reid, Susan J Knox, et al.
Translational Oncology|November 13, 2014
Rewriting the epigenetic code for tumor resensitization: a reviewBryan Oronsky, Neil Oronsky, Jan Scicinski, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|March 10, 2020
Locally advanced rectal cancer: The past, present, and futureBryan Oronsky, Tony Reid, Chris Larson, et al.
American Journal of Cancer Research|May 9, 2022
The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenograftsTony Reid, Bryan Oronsky, Nacer Abrouk, et al.
International Journal of Medical Sciences|October 14, 2022
Superficial Venous-Associated Inflammation from Direct IV Administration of RRx-001 in RatsScott Caroen, Bryan Oronsky, Tony Reid, et al.
Lancet (London, England)|September 23, 2014
Calling tuberculosis a social disease--an excuse for complacency?Petros Isaakidis, Stella Smith, Suman Majumdar, et al.
Translational Oncology|June 29, 2012
Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a reviewBryan T Oronsky, Jan J Scicinski, Tony Reid, et al.
Seminars in Oncology|June 11, 2020
Just eat it: A review of CD47 and SIRP-α antagonismBryan Oronsky, Corey Carter, Tony Reid, et al.
Molecular Cancer Therapeutics|February 1, 2024
Predicting the Abscopal Phenomenon-Letter to the EditorAnthony P Conley, Bryan Oronsky, Scott Caroen, et al.
Einstein (Sao Paulo, Brazil)|February 4, 2014
Mortality in a pediatric secondary-care hospital in post-conflict Liberia in 2009Thomaz Bittencourt Couto, Sylvia Costa Lima Farhat, Tony Reid, et al.
Translational Oncology|September 1, 2012
The scarlet letter of alkylation: a mini review of selective alkylating agentsBryan T Oronsky, Tony Reid, Susan J Knox, et al.
Translational Oncology|November 13, 2014
Rewriting the epigenetic code for tumor resensitization: a reviewBryan Oronsky, Neil Oronsky, Jan Scicinski, et al.
Pageof 13